FREMONT, Calif., Aug. 5, 2015 /PRNewswire/ -- Ardelyx, Inc.
(NASDAQ: ARDX), a clinical-stage biopharmaceutical company focused
on gastrointestinal and cardio-renal diseases, today announced that
Mike Raab, Chief Executive Officer,
will present an overview of the company at the Wedbush PacGrow
Healthcare Conference at 12:45 p.m. Eastern
Time on August 12, 2015 at Le
Parker Meridien in New York
City.
The presentation will be available through a live audio webcast
accessible through a link in the Investor Relations section of the
Ardelyx website at ir.ardelyx.com. A replay of the webcast will be
available for 14 days at the site after the presentation.
About Ardelyx
Ardelyx is a clinical-stage biopharmaceutical company
focused on the discovery, development and commercialization of
innovative, minimally-systemic, small molecule therapeutics that
work exclusively in the gastrointestinal tract to treat
gastrointestinal and cardio-renal diseases. Ardelyx has
developed a proprietary drug discovery and design platform enabling
it, in a rapid and cost-efficient manner, to discover and design
novel drug candidates. Utilizing this platform, the Company has
discovered and designed tenapanor, which it is evaluating for the
treatment of IBS-C and hyperphosphatemia in chronic kidney disease
patients on dialysis. In addition to
tenapanor, Ardelyx is developing RDX022, a non-absorbed
polymer for the treatment of hyperkalemia, or high potassium, in
kidney and heart disease patients, and has discovered small
molecule NaP2b inhibitors for the treatment of hyperphosphatemia in
CKD patients on dialysis, a program licensed to
Sanofi. Ardelyx is also independently advancing
several research programs focused in gastrointestinal and
cardio-renal diseases. Ardelyx is located
in Fremont, California. For
more information, please visit Ardelyx's website
at www.ardelyx.com.
Logo -
http://photos.prnewswire.com/prnh/20140619/119451
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ardelyx-to-present-at-the-2015-wedbush-pacgrow-healthcare-conference-300123920.html
SOURCE Ardelyx